Skip to Content

Notice

National Mammography Quality Assurance Advisory Committee; Notice of Postponement of Meeting

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is postponing the meeting of the National Mammography Quality Assurance Advisory Committee scheduled for November 2, 2009. This meeting was announced in the Federal Register of October 1, 2009 (74 FR 50803). The postponement is due to guidance documents planned for discussion at the meeting are not yet available. A future meeting date will be announced in the Federal Register.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Normica Facey, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 301-796-5914, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512397. Please call the Information Line for up-to-date information on this meeting.

Start Signature

Dated: October 9, 2009.

David Horowitz,

Assistant Commissioner for Policy.

End Signature End Further Info End Preamble

[FR Doc. E9-24895 Filed 10-15-09; 8:45 am]

BILLING CODE 4160-01-S